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Abstract
Structural biology has revealed predicting heterologous expression levels, homogeneity, and 
stability of a protein from its primary structure are exceedingly difficult. Membrane proteins, in 
particular, present numerous challenges that make obtaining milligram quantities of quality 
samples problematic. For structural and functional investigation of these molecules, however, this 
is what is required. Fluorescence size-exclusion chromatography (F-SEC), a technique where a 
protein of biological interest is fused to green fluorescent protein (GFP) and monitored, 
circumvents many bottlenecks inherent to membrane protein structural biology. In vivo expression 
yields, as well as in vitro homogeneity and stability, can be rapidly evaluated utilizing nanogram 
quantities of unpurified protein. In this chapter we describe our most current protocols for 
expression screening and biochemical characterization of membrane proteins using F-SEC, as it 
pertains to a high-throughput (HTP) crystallographic pipeline. Therein, the methods and workflow 
were designed and optimized for structure–function elucidation of eukaryotic integral membrane 
proteins, but may be applied to prokaryotic or water-soluble proteins with minor modifications, 
thus making it a useful general approach.
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1 Introduction
It is advantageous to rapidly assess in vivo and in vitro biochemical and biophysical 
behavior of a protein of biological importance before embarking on the daunting goal of 
thorough structural and functional characterization. Yet, despite developments in 
computation and other in silico tools, it is nearly impossible to predict where and to what 
relative abundance a recombinant protein will express in vivo. Moreover, in vitro evaluation 
of a protein’s folding, homogeneity, monodispersity, and stability is still very much an 
empirical endeavor.
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Researchers approximate that 30% of the human genome codes for a membrane protein, and 
that they are targets of 60% of all marketed drugs [1, 2]. As membrane proteins are 
significant constituents of the total cellular proteome and are involved in a plethora of 
essential biological processes in all kingdoms of life, detailed elucidation of their structures 
and functions are required for a complete picture of the inner workings of the cell. Indeed, of 
129,745 protein structures present in the Protein Data Bank (PDB) in May 2017, only 2207 
(1.7%) are membrane proteins, of these, a paltry 690 (0.53%) are unique three-dimensional 
folds (http://blanco.biomol.uci.edu/mpstruc/). Even with recent advances in biophysical 
techniques such as cryo-electron microscopy, brighter synchrotron sources, and 
improvements in detergent chemistry, purity, and availability, among others, membrane 
proteins are yet challenging macromolecules for structure–function investigation.
Notwithstanding their great importance, membrane proteins have proven refractory to in-
depth study due primarily to: (1) poor in vivo expression levels and (2) low in vitro stability. 
These two factors make conventional heterologous protein expression, purification, and 
subsequent structural or functional analyses difficult, as protein yields are typically in the 
realm of micrograms post-purification, and sample stability on the order of minutes to hours 
instead of days, which is required for crystallization and other structural biology 
methodologies. The physicochemical reasons that create such hurdles are multifaceted, but 
can be circumvented, or at least identified, by fluorescently tagging the membrane protein of 
interest and utilizing optical approaches to track it throughout analysis. Fluorescence 
microscopy may be coupled with a procedure termed fluorescence-detection size-exclusion 
chromatography (F-SEC), to follow the membrane protein from translation to crystallization 
[3]. Both are powerful tools in a structural biologists quest to understand a molecule’s 
physiological significance.
F-SEC takes advantage of the fact that fluorescent proteins fold even when fused in-frame to 
the N- or C-terminus of a target protein, allowing direct study and visualization of the target 
protein in vivo and in vitro [4]. F-SEC can follow specifically tagged proteins within the 
total cellular milieu, and as membrane proteins don’t express well, the high sensitivity of 
fluorescent techniques allows for detection of minute amounts of protein, instead of the 
milligram quantities necessary for traditional biochemical characterization. This easy and 
high-throughput method permits fast evaluation of target protein expression level and degree 
of homogeneity, requiring mere nanograms of unpurified whole-cell extracts with no time-
intensive, costly, protein purification. F-SEC has been used: to facilitate membrane protein 
overexpression, solubilization, and purification; as a predictor of crystallization, and, 
emphasized here, as a high-throughput means to identify high-quality membrane proteins 
amenable to structure–function analyses [3]. For these reasons, it is one of the most effective 
ways to circumvent the expression bottleneck in membrane protein structural biology, and 
can be applied to help overcome the stability impediment by temperature challenging the 
protein to determine parameters that improve a protein’s denaturation temperature (Tm) [5, 
6].
In brief, a membrane protein is cloned into a vector behind a strong promoter but in front of 
the DNA sequence that codes for enhanced green fluorescent protein (eGFP), creating a 
prototype construct [7]. Because folding of the membrane protein is a bigger challenge for 
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the heterologous expression system, it is important to place the eGFP downstream of the 
protein of interest (POI) so it ensures monitoring and purification of proper folded full-
length protein, and not stalled translations or truncations, which may be common with N-
terminally fused eGFP constructs [8]. Once the POI construct has been designed and cloned, 
human cells are transfected with plasmid DNA, allowed to recombinantly express the POI 
via incubation; then cells are removed and lysed, the POI solubilized and subjected to F-
SEC, where the POI-eGFP fusion in the mobile phase is passed over a SEC column using a 
HPLC system equipped with a fluorometer.
Here, we will describe our most current methodologies, and details for implementing a 
productive HTP F-SEC workflow for nano-scale characterization of membrane proteins. We 
will do so by focusing on the four major efficacies of F-SEC that routinely require 
optimization; expression, purification, homogenization, and stabilization; and highlight how 
F-SEC can be used at each step to overcome these problems inherent to membrane proteins. 
While the practices described can be applied to almost any target protein or expression 
system with slight modification, we will exemplify eukaryotic membrane proteins for 
intended expression in human or insect cell lines, as our interests and that of many 
researchers lie in determining human membrane protein structures. We have developed and 
refined a rapid yet robust crystallography pipeline that makes it possible to obtain highly 
pure, homogenous, and stable membrane proteins of various families or types, with no prior 
knowledge of probed molecules, for use in structure–function analyses.
2 Materials
Prepare and store all solutions according to the manufacturer or unless specifically noted. 
For cell culture work, perform all duties in a biohazard safety cabinet or equivalent and 
abide by all standard and specific safety procedures. Consult Material Safety Data Sheets for 
all chemical and biological components used, handled, and disposed of.
2.1 Design and Cloning of Constructs for Human Cell Expression
Reagents
1. Fluorescence tag fusion protein constructs: eGFP should be C-term of the POI 
followed by a purification tag if preferred (see Note 1).
2. pEGFP-N3 (Clontech, Addgene) or equivalent (see Note 2).
3. Plasmid DNA of POI (Mammalian Gene Collection/GE Dharmacon/GenScript).
4. pFastBac™1 (ThermoFisher).
1.As a first pass we suggest placing eGFP on the C-terminus of the POI as it ensures full-length protein expression and as a means to 
minimize the number of initial constructs. If the number of initial constructs is low, or focus is on only one protein ortholog, then 
placing the tag on both termini is a good option. Also, we suggest adding a purification tag, although not necessary, the construct can 
be used as a proxy for a similar construct before going large-scale.
2.pEGFP-N3mod is our lab-specific human cell F-SEC screening vector. Per Kawate and Gouaux [3], we modified pEGFP-N3 slightly 
to create a custom vector. First, we added an 8-×-Histidine tag to the C-terminus of eGFP, then made a point mutation in eGFP 
(Ala207Lys) that prevents eGFP-mediated dimerization, and finally we mutated out the XcmI restriction site in the multiple cloning 
site that lies between the BamHI site and the start codon of eGFP. This allows us to clone any gene into the pEGFP-N3mod vector 
using SalI and BamHI, where BamHI becomes a GS linker between our POI and eGFP.
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5. Cloning primers, stored at −20 °C.
6. dNTPs stored at −20 °C.
7. Phusion DNA polymerase (New England Biolabs), stored at −20 °C.
8. Restriction endonucleases (New England Biolabs), stored at −20 °C.
Equipment and Consumables
1. PCR Purification and Gel Extraction Kit (Qiagen), follow manufacturer’s 
instructions.
2.2 Transient Transfection of Human Cells
Reagents
1. HEK-293T (ATCC) or equivalent (see Note 3).
2. DMEM media: Dulbecco’s modified Eagle’s medium, high glucose, with 1% 
penicillin/streptomycin, and 10% fetal bovine serum (Gibco/ThermoFisher/
Hyclone).
3. Sequence-verified plasmid DNA with CMV promoter or equivalent (pEGFP-
N3mod).
4. jetPRIME® transfection reagent (Polyplus Transfection).
Equipment and Consumables
1. Cell countess and slides (ThermoFisher) or hemocytometer.
2. 6-, 12-, or 24-well polystyrene tissue culture-treated plates (Falcon).
3. 37 °C hydrated CO2 incubator.
4. Biohazard safety cabinet.
5. Sterile 1.5 mL Eppendorf® tubes (Fisher/Sigma-Aldrich).
6. Light microscope.
2.3 Fluorescence Microscopy
Reagents
1. 24-well polystyrene tissue culture-treated plate with transiently transfected POIs 
from Subheading 2.2.
Equipment and Consumables
1. Nikon Ti fluorescence microscope or equivalent (Nikon).
2.4 F-SEC Sample Preparation
Reagents
3.HEK-293T cells are preferred but any derivative including HEK-293S GnTI- or HEK-293ES may be used.
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1. Resuspension buffer: 0.2 μm filtered 25 mM Tris pH 7.4, 150 mM NaCl, 1 mM 
PMSF (phenylmethanesulfonyl fluoride), and cOmplete™ EDTA-free protease 
inhibitor tablets (Sigma-Aldrich).
2. βDDM (n-dodecyl-β-D-maltoside) (Anatrace/Inalco). Prepare a 10% stock by 
weighing 1 g and add DI water to 10 mL (see Note 4).
Equipment and Consumables
1. Squared-end stainless steel lab spatula (Fisher).
2. Thick-walled 1.5 mL Microcentrifuge polypropylene tubes (Beckman-Coulter).
3. Eppendorf® tabletop centrifuge, Microcentrifuge or equivalent (Sigma-Aldrich).
4. Nalgene™ 1 L 0.2 μm filter unit (Fisher).
5. Parafilm M®.
6. Nutator or rotating mixer.
7. Small tip or handheld sonicator.
8. TLA-55 Ultracentrifuge rotor (Beckman-Coulter).
9. Optima™ Ultracentrifuge (Beckman-Coulter).
10. 0.2 μm centrifugal spin filters (Millipore/Corning).
11. NanoDrop spectrophotometer (Cole-Parmer/ThermoFisher).
Prepare Resuspension buffer beforehand by adding appropriate amounts of high 
concentration liquid stock solutions or dry powder, adding 4 °C water to volume, and then 
filtering through 0.2 μm filter unit.
All experiments should be run at 4 °C or on ice to prevent protein degradation, unless 
otherwise noted.
2.5 F-SEC
Reagents
1. SEC buffer: Resuspension buffer (from above) plus 0.1% βDDM.
2. βDDM (n-dodecyl-β-D-maltoside).
Equipment and Consumables
1. HPLC (Shimadzu/Amersham/GE Healthcare Life Science).
2. RF-10AXL Fluorometer or equivalent (Shimadzu Scientific).
3. Superdex 200 Increase 10/300 GL column (GE Healthcare Life Sciences).
4. Shimadzu flat-bottom or tapered autosampler vials (Shimadzu Scientific).
4.Other detergents can be tried for solubilization but in our experience βDDM is the detergent of choice for initial screening of 
membrane proteins of all sizes and topologies. Usually once a target protein has been identified after F-SEC, a panel of detergents can 
be used to screen for solubilization of the well-expressing protein during purification optimization.
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5. 4 °C deli case for storage of whole HPLC system.
6. PCR tubes.
7. PCR Thermal Cycler (MJ Research).
8. 0.2 μm centrifugal spin filters (Millipore/Corning).
Prepare SEC buffer beforehand by adding 10 mL of 10% βDDM stock to 990 mL 
Resuspension buffer, then filter with 0.2 μm unit.
All experiments should be run at 4 °C or on ice to prevent protein degradation, unless 
otherwise noted. HPLC is stored at 4 °C in a deli case for these purposes.
2.6 Electrophoretic Assessment of F-SEC Samples
Reagents
1. SDS-PAGE running buffer and 2× Laemmli sample buffer (Bio-Rad).
2. Sodium deoxycholate (Sigma-Aldrich).
3. βDDM (n-dodecyl-β-D-maltoside) (Anatrace/Inalco).
Equipment and Consumables
1. Mini-PROTEAN® TGX™ precast 4–20% polyacrylamide gels (Bio-Rad).
2. Novex® NativePAGE™ Bis-Tris Gel System (ThermoFisher).
3. Native-PAGE™ 4–16% Bis-Tris Gels (ThermoFisher).
4. Typhoon Biomolecular imager (Amersham/GE Healthcare Life Sciences).
All experiments should be run at room temperature, while the samples should be kept at 
4 °C or on ice until use, unless otherwise noted.
2.7 Design and Cloning of Constructs for Insect Cell Expression
Reagents
1. pEGFP-N3mod with cloned POI, or equivalent (see Note 2).
2. pFastBac™1 (ThermoFisher).
3. Cloning primers, stored at −20 °C.
4. dNTPs stored at −20 °C.
5. Phusion DNA polymerase (New England Biolabs), stored at −20 °C.
6. Restriction endonucleases (New England Biolabs), stored at −20 °C.
Equipment and Consumables
1. PCR Purification and Gel Extraction Kit (Qiagen), follow manufacturer’s 
instructions.
2. Site-directed mutagenesis kit (Agilent).
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2.8 Generating Bacmid and Baculovirus for POI Using Insect Cells
Reagents
1. Sequence-verified plasmid DNA with polH promoter or equivalent (pFastBac1).
2. E. coli DH10Bac™ cells (ThermoFisher).
3. SOC media.
4. Antibiotics: kanamycin, tetracycline, and gentamycin.
5. IPTG (isopropyl β-D-1-thiogalactopyranoside).
6. Bluo-Gal (ThermoFisher).
7. Blue-white colony plates: Luria agar, 40 μg/mL IPTG, 50 μg/ mL Kanamycin, 10 
μg/mL Tetracycline, 7 μg/mL Gentamicin, 100 μg/mL Bluo-Gal.
8. Miniprep Kit: Solution 1—15 mM Tris pH 8.0, 10 mM EDTA, 100 μg/mL 
RNase A, Solution 2—0.2 N NaOH, 1% SDS, Solution 3—3 M potassium 
acetate pH 5.5.
9. Platinum Taq polymerase, stored at −20 °C.
10. dNTPs stored at −20 °C.
11. pUC/M13 forward and reverse primers.
12. Sf9 cells adapted to ESF 921 media (Expression Systems) (see Note 5).
13. Effectene® transfection reagent (Qiagen).
14. ESF 921 media (Expression Systems).
Equipment and Consumables
1. 14 mL round bottom polypropylene tubes (Falcon).
2. 6-well polystyrene tissue culture-treated plates (Falcon).
3. Erlenmeyer flasks, polycarbonate or glass, non-baffled, sterile (Corning/Fisher).
4. Swing-bucket centrifuge.
5. Sterile syringes and 0.2 μm syringe filter units (Pall).
6. 37 °C incubator.
7. 27 °C incubator and incubator shaker.
8. PCR Thermal Cycler (MJ Research or equivalent).
9. DNA electrophoresis station.
10. Gel visualizer and analyzer.
11. Light microscope.
5.No antibiotics should be present, and FBS or BCS are not necessary, media should be serum free.
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12. Biohazard safety cabinet.
All experiments should be run at room temperature, unless otherwise noted.
2.9 Optimizing POI Expression, Stability, and Purification
Reagents
1. Sf9 and Tn5 (High Five) cells adapted to ESF 921 media (Expression Systems).
2. ESF 921 media (Expression Systems).
3. P1 virus from Subheading 2.8.
4. Resuspension buffer Subheading 2.4.
5. Various detergents (Anatrace), lipids (Avanti), and cholesteryl hemisuccinate 
(Anatrace).
Equipment and Consumables
1. 150 mL Erlenmeyer flasks, polycarbonate or glass, non-baffled, sterile (Corning/
Fisher).
2. 23–27 °C orbital incubator shaker.
3. Biohazard safety cabinet.
4. Thick-walled 1.5 mL Microcentrifuge polypropylene tubes (Beckman-Coulter).
5. Eppendorf® tabletop centrifuge, Microcentrifuge or equivalent (Sigma-Aldrich).
6. 15 mL and 50 mL conical tubes (Falcon).
7. Small tip or handheld sonicator.
8. PCR thermocycler.
9. 0.2 μm spin filters (Millipore).
10. Ultracentrifuge, rotors, and tubes (Beckman-Coulter).
11. Dounce homogenizer (Corning).
All experiments should be run at room temperature, unless otherwise noted.
All cell culture experiments should be performed in a biohazard safety cabinet using sterile 
technique.
3 Methods
3.1 Design and Cloning of Constructs for Human Cell Expression
Utilizing the power of life’s natural codon diversity to aid in the impossible task of 
predicting heterologous protein expression from a protein’s nucleic or amino acid sequence, 
we first select a primary human POI and then compare sequences of orthologous or even 
paralogous proteins using standard bioinformatics practices. For one primary human POI we 
usually screen ~20 additional homologous membrane proteins, mostly orthologs, aiming for 
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as much genetic diversity as possible by testing the same protein through evolution from fish 
to mammals, and depending on the protein family, insects, worms, and plants are added as 
needed. As a rough estimate, we aspire for no less than 50% identity in a given ortholog’s 
amino acid sequence compared to the primary POI. By screening a large number of 
orthologous proteins, we increase the likelihood of obtaining one high-quality protein with 
similar structure and function to the initial molecule of importance, in the event that the 
primary POI is recalcitrant to expression or crystallization.
Our constructs typically include, reading from N- to C-terminus: (1) a Kozak sequence 
followed by a start codon, (2) the protein-of-interest (POI), (3) a short three amino acid 
linker, (4) eGFP, and finally (5) the purification tag of choice, followed by a stop codon (see 
Note 6). The POI and all homologous proteins are cloned into the same restriction sites, and 
since all constructs have the same design, total expression amounts and homogeneity are a 
true representation of the difference in each homolog and not of the place of the eGFP or 
purification tag, etc. eGFP is a modified version of wild-type GFP with enhanced fluorescent 
brightness, codon-optimized for human cell expression, and containing a A206K mutation 
that disrupt eGFP dimerization.
1. Design your constructs in a similar manner to what is described above.
2. Clone using your method or vendor of choice.
3.2 Transient Transfection of Human Cells
Transiently transfect HEK-293T cells with pEGFP-N3 plasmid DNA with your POI cloned 
behind the CMV promoter. HEK cells are transfection-optimized cells, but must be passaged 
to a confluency no higher than 90% before transfection. If the cells at any point reach higher 
confluency, discard and thaw a new stock before trying transfection again, as cells that reach 
high confluency can result in poor heterologous expression.
For the purposes of this procedure we are assuming 22 genes are being screened so that the 
appropriate tissue culture plate will be a 24-well platform, which will include two control 
wells.
All portions of the procedure should be conducted in a biohazard safety cabinet using sterile 
technique at room temperature, unless otherwise noted.
The time from transfection start to finish, not including seeding and expression incubations 
is ~1 h.
1. Take monolayer adherent HEK-293T cells from a stock tissue culture dish at a 
confluency <90% in DMEM supplemented with antibiotics and 10% FBS and 
seed into a 24-well tissue culture plate at a confluency ~35% (see Note 7).
6.(1) Kozak sequence we use is GCCACCATG, with ATG being the start codon. (3) The short amino acid linker may be present or not 
depending on the amount of disorder predicted in the C-terminus of the POI. Our linker is Gly-Ser in most cases, which is the BamHI 
cloning site (GGATCC). (5) Our lab uses at least an 8× histidine tag, but the tag length and type may be adjusted depending on end 
use or results from F-SEC. It is not necessary to purification tag your F-SEC screening constructs but we find it helpful for 
downstream analyses while waiting for cloning of altered or eGFP-less constructs.
7.This procedure is dedicated to 22 POIs, but this number can be adjusted as well as the number of wells required for the tissue culture 
plate. A 6-well plate has over 4× the surface area of a 24-well plate, so it is possible to adjust the procedure if more cells are expected 
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2. Dilute cells to a density of ~1 × 105 cells/mL and add 500 μL to each well of a 
24-well plate (~5 × 104 cells per well).
3. Allow to adhere by incubating at 37 °C in a humidified chamber with 5% CO2 
supplementation overnight.
4. Next day, visualize cells under light microscope to ensure confluency between 70 
and 80% (~1 × 105 cells per well). If higher, reseed at a lower confluency and 
repeat steps 1 and 2.
5. In sterile 1.5 mL Eppendorf® tubes add 50 μL jetPRIME® buffer and 500 ng 
pEGFP-N3 plasmid DNA for each POI (see Note 8).
6. Vortex mixtures for 10 s, then centrifuge briefly and incubate for 2 min at room 
temperature.
7. Add 1 μL of jetPRIME® transfection reagent to each tube.
8. Vortex mixtures for 10 s, then centrifuge briefly and incubate for 10 min at room 
temperature.
9. Add whole transfection mixtures corresponding to each POI to individual wells 
on the 24-well plate.
10. Treat a positive and negative control well appropriately per steps 5–9 (see Note 
9).
11. After 4 h, but ONLY if necessary, aspirate off transfection mixture from cells and 
quickly add back 500 μL of fresh DMEM supplemented with antibiotics and 
10% FBS (see Note 10).
12. Allow to incubate at 37 °C for 48 h in a humidified chamber with 5% CO2 
supplementation.
3.3 Fluorescence Microscopy
Before harvesting cells for F-SEC analysis it is suggested the plate be visualized under a 
fluorescence microscope to assess in vivo cellular compartmentalization and gross gene 
expression levels, as the intensity of the fluorescence signal approximates total protein 
expression.
The experiment is performed within an hour and should be run at room temperature. It is not 
necessary to perform microscopy under sterile conditions since the cells will be harvested 
directly after visualization, but care must be taken to not contaminate individual samples.
to be required. In our experience, variability in seeding densities per well makes it preferable to do all transfections at once on the 
same plate platform, however.
8.Follow the transfection protocol per the manufacturer’s short DNA transfection protocol. This procedure can be altered for other 
plate sizes or optimized for better transfection efficiency, if needed.
9.For a negative control we treat the cells with transfection mixture without any plasmid DNA added. For a positive control we use a 
membrane POI that expresses well as our transfection control. Alternatively, you could use the pEGFP-N3 vector alone as the positive 
control, which will express soluble eGFP. This is less preferable, but adequate as a means to visualize transfection efficiency.
10.In our experience, it is not required and sometimes detrimental to remove the reaction and media, as the thin monolayer of cells 
may dry out in the 24-well plate format. It is best to leave the experiment alone, in our estimation.
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1. Take the 24-well plate to a fluorescence microscope (see Note 11).
2. Turn power on to microscope, computer, and all accessory components.
3. Visualize bright field and fluorescence individually and merged in each well, 
including the control wells using your eye or software of choice.
4. Normalize fluorescence exposure times to the positive control protein to 
approximate best expressing homologs (see Note 9).
5. Note in what organelle, plasma membrane, or cellular compartment your POI 
migrates to.
6. Quantify transfection efficiency by comparing bright field and fluorescence 
images of the positive control and all POIs screened as in Fig. 1.
7. Save jpeg or equivalent images of each well for comparative analyses.
3.4 F-SEC Sample Preparation
For the purposes of this protocol, βDDM (see Note 5) is the detergent of choice for optimal 
membrane protein extraction and stability, as it has proven to be a mild, non-denaturing 
detergent, relatively cheap, and the most popular detergent for crystallization of many 
classes of membrane proteins [9]. In the case of HEK-293T cells, complete lysis occurs after 
treating the cells with detergent. However, for insect cells, E. coli, or yeast expression 
systems, cell lysis must be achieved via sonication, French press, bead beater, or alternate 
means before solubilization can be attempted.
1. With a squared-end stainless steel lab spatula gently scrape off monolayer cells 
from each individual well, and using a pipette, remove entire ~500 μL of 
dislodged cells and media into a fresh 1.5 mL thick-walled Microcentrifuge tube 
(see Note 12).
2. Using a tabletop centrifuge, spin each sample tube at 16,000 × g for 1 min to 
pellet the unlysed cells.
3. Vacuum aspirate off supernatant DMEM media.
4. Add 500 μL of Resuspension buffer to each tube of pelleted cells and vortex 
gently to homogenize the samples (see Note 13).
5. Add 50 μL of 10% βDDM stock to each sample tube.
6. Parafilm M® wrap the caps of each tube (see Note 14).
11.Our lab uses a Nikon Ti microscope equipped with Nikon DS-Qi2 fluorescence and DS-Ri2 color cameras, a Sutter Lambda LS-2 
xenon arc lamp, and Sutter excitation and emission filter wheels. For 10× and 20× magnification the scope is equipped with 0.45 and 
0.75 Plan Apo lenses, respectively. The filter set for eGFP is a Chroma 89021 ET with excitation and emission at 470 and 525 nm. The 
software, NIS-Elements 4.30 (Nikon), runs on a PC with 64-bit Windows 7 Pro (Microsoft), a Core 2 Duo E8500 (Intel) processor, 
and NVI-DIA Quadro NVS 290 graphics card (HP).
12.It is possible to remove the DMEM media first by vacuum aspiration before scraping off the monolayer but we have noticed that 
HEK-293T cells tend to become detached after transfection and the possibility exists that you will lose sample by first aspirating; 
adding the entire experiment to a centrifuge tube first allows for recovery of all cells.
13.At this point in the protocol the procedure may be halted by placing the cells in Resuspension buffer and flash freezing them in 
liquid nitrogen then placing in −80 °C until use. We have observed no change in F-SEC results or harm to the samples after freezing, 
and they are fine for up to 1 month or more.
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7. Place tubes on nutator or rotating mixer and agitate for ≥ 1 h at 4 °C (see Note 
15).
8. After time, place thick-walled Microcentrifuge tubes in a TLA-55 
Ultracentrifuge rotor and centrifuge at 4 °C with an Optima™ Ultracentrifuge at 
100,000 × g (47,000 rpm) for 30 min (see Note 16).
9. During centrifugation, equilibrate the SEC column in SEC buffer and warm up 
the xenon lamp on the fluorometer (Subheading 3.5).
10. After centrifugation, remove sample supernatant from each tube with a pipette 
and place in 0.2 μm centrifugal spin filters.
11. Spin samples at 16,000 × g for 1 min using a tabletop centrifuge.
12. Place samples on ice, and take A280 nm readings using a spectrophotometer (see 
Note 17).
The time from start to finish for F-SEC sample preparation is ~2 h.
3.5 F-SEC
During ultracentrifugation, step 8 in Subheading 3.4, it is advisable to equilibrate the SEC 
column in SEC buffer and warm up the xenon lamp on the fluorometer. It is assumed that 
the HPLC of choice along with SEC column has been properly stored in DI water or 20% 
ethanol before beginning F-SEC, and that the system/column are in good working order with 
clean filters and no pressure issues. The time from start to finish for F-SEC is ~35 min per 
sample depending on autosampler speed. Assuming 22 POI samples with two controls and 
two QC samples, total experimental time is ~15 h.
1. Turn on power to computers, controller, and all components of HPLC system 
(see Note 18).
2. Remotely or manually turn the xenon lamp on the RF-10AXL fluorometer (see 
Note 19).
3. Connect a Superdex 200 Increase 10/300 GL SEC column post injection port and 
pre fluorescence detector.
14.Beckman Microcentrifuge tubes don’t seal/snap tightly and you could lose your samples.
15.Some membrane proteins are notoriously difficult to solubilize and may require longer incubation times with detergent, up to 4–24 
h. For the purpose of this HTP protocol we will assume this isn’t the case.
16.Solubilization does not need to occur in thick-walled Microcentrifuge tubes but sample may be lost transferring from non-thick-
walled Eppendorf® tubes to these tubes. Care must be taken that the proper tubes are used for Ultracentrifugation, and non-thick-
walled tubes will fail under high pressure, sample will be lost, and the rotor at high velocity could become unbalanced and hazardous.
17.It is important to load the same amount of total protein for each sample for F-SEC. The A280 nm reading of the total cell lysate 
will be left shifted, but in our experience most samples should have similar protein concentration. This step is necessary in case they 
do not, so that the loading volumes can be adjusted to account for divergences. This step will be useful in F-SEC as well as in-gel 
fluorescence SDS-PAGE for quantifying expression of the POI.
18.Our lab uses Shimadzu Prominence HPLCs equipped with LC-10ADVP or LC-20AD pumps, SCL-10AVP controllers, FRC-10A 
fraction collectors, SIL-10AP autosamplers, SPD-M10AVP or SPD-M20A diode arrays, and RF-10AXL or RF-20A fluorescence 
detectors; and use Shimadzu LabSolutions or CLASS-VP software on a PC running either Windows 7 or Windows XP.
19.For normal F-SEC procedures it is not necessary to turn on a diode array or UV detector, as the A280 nm trace is mostly 
meaningless with whole-cell extracts. Turning it on does little to help interpretation, and only diminishes lamp life.
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4. With no flow rate, place HPLC pump line from DI water to 1 L SEC buffer (see 
Note 20).
5. Download a method to the system with xenon lamp on (λex = 488 nm and λem = 
509 nm), and a pump flow rate of 0.75 mL/min (see Note 21).
6. Allow ample time for system lines and SEC column to be equilibrated in buffer, 
typically 1 h at 0.75 mL/min is sufficient for 1× column volume.
7. After the HPLC system is warmed up and system lines and SEC column are 
equilibrated in SEC buffer, pipette 200 μg of filtered solubilized protein into 
Shimadzu flat-bottom or tapered autosampler vials.
8. Place samples in the autosampler rack in a meaningful order.
9. Prepare QC samples consisting of fluorescent protein standard and 1 M NaOH 
(see Note 22).
10. Input information and save sequence run file corresponding to injection of a 
volume consistent with 200 μg of each POI queried, plus the positive and 
negative HEK cell controls (24 in all).
11. Run each sample at a flow rate of 0.75 mL/min for 35 min while monitoring 
fluorescence.
12. After time, scale all chromatogram data to the transfection positive control, QC 
fluorescent protein standard, or most intense POI sample.
13. Compare individual POI expression levels (fluorescence intensity) and 
homogeneity/monodispersity (peak symmetry, Gaussian) to find the best 
expressing, most behaved POI homolog, as in Fig. 2.
3.6 Electrophoretic Assessment of F-SEC Samples
In parallel to F-SEC, and using the same sample, you can visualize total protein expression, 
protein homogeneity, and potential oligomerization by coupling the chromatographic 
technique highlighted in Subheading 3.5 with SDS-PAGE and Native-PAGE electrophoresis. 
This workflow allows for a visualization of the sample before it is subjected to the rigors of 
SEC purification, and is often a supplementary tool in qualitative and quantitative 
assessment of in vitro protein behavior.
20.With 22 samples, and two QC samples at a constant flow rate of 0.75 mL/min, we estimate 720 mL of buffer will be required for 
this analysis. That assumes ~30 mL per sample for 24 samples. It is important to make more buffer than is necessary, as air in the 
system and on column will damage each and make data interpretation problematic.
21.Take care to ensure the flow rate is comfortably below the pressure limit of the SEC column, as you’re injecting crude lysates, 
although filtered, can precipitate over time.
22.This step is optional. However, we always run a fluorescent protein standard consisting of an amount of purified eGFP that 
corresponds to ~700 mV of fluorescence signal from the detector. This ensures that the detector lamp is fully functional and not 
dimming over runs and for comparative purposes. Since each detector will need to be individually calibrated, you will need to 
determine your lamps range empirically. Additionally, the last sample injected after all POIs and standards are run is 500 μL of filtered 
1 M NaOH to clean the column of precipitated or aggregated small and large molecules.
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3.6.1 SDS-PAGE
1. Prepare SDS-PAGE running buffer, electrophoresis chambers, and precast gels 
per manufacturers or lab standard protocols (see Note 23).
2. Take centrifuged and filtered samples as prepared via Subheading 3.4 and 
remove 10–30 μg of total protein and place in a 1.5 mL microcentrifuge tube.
3. Add the appropriate volume of 2× Laemmli buffer to each sample for a final 1× 
concentration (DO NOT boil membrane protein samples, doing so results in 
aggregation in SDS-PAGE).
4. Load 4–20% polyacrylamide gel wells with protein samples, with molecular 
weight standard if required.
5. Assemble electrophoresis chamber and run samples at 250 V for 25 min at room 
temperature.
6. Remove gel from chamber and place in deionized water.
7. Visualize in-gel fluorescence using a Typhoon Biomolecular imager or 
equivalent with a blue light filter, as per Fig. 3 (see Note 24).
The time from start to finish for SDS-PAGE is ~0.75 h.
3.6.2 Native-PAGE
1. Prepare NativePAGE™ Bis-Tris Gel System chambers and gels per 
manufacturers or lab standard protocols (see Note 25).
2. Take centrifuged and filtered samples as prepared via Subheading 3.4 and 
remove 10–30 μg of total protein and place in a 1.5 mL microcentrifuge tube.
3. Add the appropriate volume of 4× NativePAGE™ sample buffer to each sample 
for a final 1× concentration, and place samples on ice.
4. Make 1× NativePAGE™ Anode buffer per manufacturer’s specifications.
5. Make 1× Cathode buffer by adding 50 mM Tricine pH 7.0, 7.5 mM Imidazole, 
0.02% βDDM, and 0.05% sodium deoxycholate and dilute to 200 mL with 
deionized water (see Note 26).
6. Load 4–16% polyacrylamide gel wells with protein samples, with native 
molecular weight standard if required.
23.We utilize the SDS-PAGE system and gels from Bio-Rad.
24.Visualization input for Typhoon Biomolecular Scanner: Acquisition Mode Fluorescence, using the 520 BP 40 filter (Blue2 488 
nm), PMT of 500, Normal sensitivity, Platen focal plane.
25.The protocols for the Novex® NativePAGE™Bis-Tris gel system Blue Native-PAGE procedure from ThermoFisher are essentially 
followed exactly (https://www.thermofisher.com/content/dam/LifeTech/global/life-sciences/ProteinExpressionAnalysis/pdfs/
NativePAGE_Bis-Tris%20Gels_Protocol.pdf).
26.Because Coomassie G-250 interferes with in-gel fluorescence detection of eGFP, the Blue Native-PAGE protocol has been 
modified based on the high-resolution Clear Native-PAGE methodology published by Wittig et al. [10]. By exchanging Coomassie 
G-250 dye for βDDM and sodium deoxycholate, membrane proteins obtain the necessary negative charge to move toward the 
positively charged anode, while still maintaining their native protein fold. Since all membrane proteins have variable charge and size 
distributions, the cathode buffer may need to be optimized for high-resolution clear Native-PAGE, which might include alternate 
concentrations or types of non-denaturing detergents and concentrations of sodium deoxycholate.
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7. Assemble electrophoresis chamber and run samples at 150 V for 120 min at 
room temperature or 4 °C.
8. Remove gel from chamber and place in deionized water.
9. Visualize in-gel fluorescence as in SDS-PAGE step 7, as per Fig. 3.
The time from start to finish for Native-PAGE is ~2.5 h.
3.7 Design and Cloning of Constructs for Insect Cell Expression
At this point in the workflow, after F-SEC and electrophoresis-coupled in-gel fluorescence 
(Figs. 2 and 3), you will have an idea of the 1–2 top expressing, most homogenous and 
monodisperse membrane protein homologs from human cells. From here we move from 
human cells to an analogous expression system capable of making copious amounts of high-
quality membrane POIs that is scalable once nano-scale characterization is complete. The 
baculovirus system using insect cell lines is a popular choice because it can robustly 
overexpress prokaryotic and eukaryotic proteins, and its methods are relatively affordable 
while being highly reproducible. One drawback of the baculovirus system is its throughput, 
where going from DNA to protein may take up to 15–20 working days. Our workflow has 
been engineered to be as high-throughput as possible. Toward this goal we designed our 
human expression system vector pEGFP-N3mod (see Note 2) to be transferable to 
baculovirus with a straightforward cut and paste cloning strategy of our entire POI-eGFP-
Histidine tag fusion into pFastBac1 (see Note 27).
1. Clone out the best expressing and most monodisperse constructs from pEGFP-
N3mod into pFastBac1 using the restriction enzymes SalI and NotI. The time 
from start to finish for cloning is ~5 days.
2. Add any desired modification to the construct via site-directed mutagenesis.
3. Sequence verify cloned genes.
3.8 Generating Bacmid and Baculovirus for POI Using Insect Cells
1. Using sequence-verified plasmid DNA cloned into the pFastBac1 vector, 
transpose E. coli DH10Bac™ cells and verify proper bacmid generation per 
manufacturer’s protocols (see Note 28).
2. See Subheading 2.8 for a list of what is typically needed.
3. Once bacmid DNA has been PCR verified and in hand, seed a 6-well tissue 
culture plate with 2 mL of monolayer or suspension-adapted Sf9 cells at a 
concentration of 4.5 × 105 cells/mL (~1 × 106 cells per well) in serum-free 
media.
27.The design of pEGFP-N3mod allows us to cut out all POI homologs using SalI and NotI from the human expression vector and 
paste the POI into pFastBac1 using the same strategy, as both vectors contain these two restriction sites in their multiple cloning sites. 
This scheme allows for the constructs designed in Subheading 3.1 to be used for scale-up in baculovirus expression systems, and for 
the POI-eGFP-Histidine construct to be utilized for nano-scale optimization of expression, purification, and stabilization.
28.We utilize the Bac-to-Bac® Baculovirus Expression Systems technology and follow the protocols outlined in the manual provided 
by Invitrogen™ and ThermoFisher. Although, we believe a previous version to be more helpful, found here: http://wolfson.huji.ac.il/
expression/bac.pdf.
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4. Incubate on a flat surface at room temperature for 1 h to allow cells to adhere.
5. Transiently transfect Sf9 cells by adding 50 μL of Buffer EC to a sterile 
microcentrifuge tube, followed by 1 μg of bacmid DNA and 5 μL of Enhancer.
6. Vortex for 1 s then spin down quickly using a centrifuge, and allow to incubate 
together for 5 min at room temperature.
7. After time, add 10 μL of Effectene® transfection reagent, vortex for 10 s and 
spin down again and allow to incubate at room temperature for 20 min.
8. After time, add 50 μL of fresh EC buffer and add dropwise the entire transfection 
mix to one well of the 6-well plate.
9. Place in humidified chamber, protected from light, and incubate at 27 °C for 4 
days.
10. During transfection observe viral amplification using a light microscope (see 
Note 29).
11. After time, harvest the P0 virus by removing transfection supernatant with sterile 
5 mL syringe and pass through 0.2 μm syringe filter.
12. Then, to a 50 mL suspension culture of Sf9 cells at ~2 × 105 cells/mL add ~100 
μL of P0 virus and allow to amplify for 2–6 days at 27 °C while rotating at 125 
rpm.
13. After time, harvest the P1 virus by placing cells and media into a sterile 50 mL 
conical tube and centrifuging in a swing-bucket centrifuge at 500 × g for 10 min, 
then decant the supernatant into a new sterile 50 mL conical tube.
14. Titer the 50 mL P1 virus using your preferred methodology (see Note 30).
The time from start to finish for transposition, transfection, virus generation, and titering is 
~15 days.
3.9 Optimizing POI Expression, Stability, and Purification
While the information gathered from F-SEC in human cells is critical for the next steps of 
optimization, it has given us no discernable data on protein stability. Moreover, due to the 
high-throughput design of the human cell expression protocols it is unclear whether protein 
expression levels may be improved. Using a POI-eGFP fusion in the baculovirus expression 
system one can rapidly test variables that boost protein expression, screen additives that 
increase protein stabilization, and optimize protein behavior and yields during purification.
29.For transfection it is important to have a negative and, preferably, a positive control. The negative control consists of transfection 
reagents added to cells without bacmid DNA, and positive control consists of a previously expressing POI P1 virus. By comparing 
infection and amplification of the two controls and the POIs, you can gauge successful transfection. For instance, cells for the positive 
control should cease doubling within 1–2 days, that of the transfection should cease doubling within 2–4 days, while the negative 
control should not cease doubling. Also, infection with baculovirus particles will make the Sf9 cells swell slightly and start to adhere 
in the monolayer less. By comparing cell morphologies, adhesion, and confluencies you can accurately track positive transfection of 
your POI.
30.Titering is essential for optimizing protein expression, which in turn is required for optimizing purification and stability, so we 
highly recommend titering all baculovirus stocks. The plaque assay is one method of titering virus, explained in the Bac-to-Bac® 
Baculovirus Expression Systems manual, although throughput is not optimal.
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3.9.1 Expression—The following is an expression experiment meant to rapidly screen 
time, temperature, and MOI, three common parameters to vary toward obtaining the most 
homogeneous protein sample.
1. Seed six sterile, non-baffled, glass 150 mL Erlenmeyer flasks with 50 mL of 1 × 
106 cells/mL suspension-adapted Sf9 cells in serum-free media.
2. Incubate overnight at 27 °C in shaking incubator set to 125 rpm.
3. Next day, add the appropriate volume of titered P1 virus for one POI to each 
culture for a multiplicity of infection (MOI) of 0.2, 2.0, and 20.0, in duplicate 
(see Note 31).
4. Incubate at 27 °C in shaking incubator set to 125 rpm for 24 h.
5. Next day, remove 5 mL of culture from all six flasks and pipette into 15 mL 
conical tubes.
6. Centrifuge 15 mL conicals at 3,200 × g(4,000 rpm) for 5 min, vacuum aspirate 
off the media and place samples in −80 °C until use.
7. Then take three flasks with each MOI and place at 23–24 °C in shaking 
incubator set to 125 rpm while leaving the other three flasks at 27 °C shaking at 
125 rpm.
8. Every 24 h from initial inoculation, remove 5 mL culture from all six flasks, up 
to 120 h.
9. After 120 h, remove samples from −80 °C in 15 mL conicals and allow to thaw 
on ice.
10. Add 1 mL of Resuspension buffer to each of 30 samples, transfer contents to 
thick-walled Microcentrifuge tubes, and sonicate using a small tip or handheld 
sonicator to lyse the Sf9 cells.
11. Follow the sample preparation procedure outlined in Subheading 3.4, steps 5–12.
31.For instance, two flasks with MOI of 0.2, two with MOI of 2.0, and two with MOI of 20.0. It is also possible to alter the MOIs 
tested to 0.1, 1.0, and 10.0. MOI is the ratio of virus to cells and can be calculated by the following formula: Formula:
Desired MOI (pfu/mL) × (Total number of cells)
Titer of viral stock inoculum (pfu/mL)
= Inoculum required (mL)
Example:
2.0 (pfu/mL) × (2 × 106cells/mL × 50 mL)
1 × 109(pfu/mL)
= 0.2 mL P 1 virus added to 50 mL culture
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12. After solubilization of expression samples, perform F-SEC and in-gel SDS-
PAGE analyses on all 30 samples per Subheadings 3.5 and 3.6.1, highlighted in 
Fig. 4 (see Note 32).
13. Using the identical method, test alternate cell lines such as Tn5 or Sf21 and 
compare the highest expression parameters in those cells to Sf9, for maximizing 
yields.
The time from start to finish for expression assessment is ~6 days.
3.9.2 Stability—Once it is determined which time, temperature, and MOI is best for 
obtaining high amounts of monodisperse protein, use the remaining sample from that aliquot 
and determine the protein’s thermostability in the standard F-SEC buffer in βDDM. The 
following method is based on the assay developed by Hattori et al. [6]. At the end of the 
experiment you will obtain the Tm of the protein in solution, the denaturation temperature 
where half of the protein remains in a folded state. This is the temperature that serves as a 
reference point for testing the effects of small molecule additives on protein 
thermostabilization.
1. Remove pre-F-SEC, post-solubilization sample in thick-walled Microcentrifuge 
tube and aliquot 50–200 μg total protein into ten PCR tubes.
2. Label each tube 1–10.
3. Using a standard PCR Thermal Cycler, place tube 1 in the cycler and create a 
method with a step 1 temperature of 4 °C for 10 min, followed by a step 2 hold 
at 4 °C for ∞.
4. When ready, take tube 1 from cycler and remove precipitate by transferring 
sample to 0.2 μm centrifugal spin filter.
5. Place sample in autosampler vials and place in autosampler rack at 4 °C.
6. Repeat steps 3–5 for the remaining nine samples, but increase PCR step 1 
temperature for each sample by 10 °C intervals, for a final temperature range 
from 4 to 94 °C.
7. Once all ten samples have been temperature challenged and filtered, perform F-
SEC analysis per Subheading 3.5, with representative results shown in Fig. 5.
8. Determine the melting temperature, Tm, by plotting fluorescence peak intensity/
peak area (mV) versus temperature (°C) and fitting the curve to a sigmoidal 
dose-response equation, as in Fig. 5 (see Note 33).
32.We find by performing this nano-scale procedure in 50 mL suspension it better mimics larger scale protein production that will be 
used in the future. By coupling in-gel SDS-PAGE and F-SEC there should be a clear trend indicating the best time, temperature, and 
MOI where the most monodisperse protein is obtained. The alternate temperatures used in this experiment account for the fact that 
some membrane proteins tend to be toxic when overexpressed, and lowering the culture temperature and increasing the MOI often 
favor better expression. One could also do in-gel Native-PAGE, but we find it not necessary in most cases.
33.As temperature increases the F-SEC profiles of the protein will change by slowly decreasing in fluorescence intensity, and/or 
decreasing elution volumes and eventual inclusion into the void caused by protein aggregation. See Hattori et al. [6] and Kumari et al. 
[11] for more information on curve fitting.
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9. Assess the effect of small molecules such as osmolytes, cholesterol, lipids, 
known ligands or ions, and detergents on protein stability by adding them to the 
post-βDDM-solubilized sample and challenging at the experimental Tm, per Fig. 
5 (see Note 34).
The time from start to finish for thermostability assessment is ~1 h per sample using F-SEC-
based methods.
3.9.3 Purification—Once a Tm is established as in Fig. 5, protocols for optimizing 
protein stability and purification should go hand-in-hand. Here, the POI-eGFP-Histidine tag 
construct can be scaled up to the milli-scale levels required for structure–function studies. At 
this point you should know: (1) which POI expresses best and is most homogenous, (2) the 
insect cell type and expression parameters that result in the highest amount of monodisperse 
protein, and (3) the Tm of the protein in F-SEC buffer pH 7.4 with βDDM and the effect of 
select additives on the protein’s thermostability.
1. Seed a sterile, non-baffled 150 mL Erlenmeyer flasks with 50 mL of 1 × 106 
cells/mL suspension-adapted insect cells in serum-free media.
2. Incubate overnight at 27 °C in shaking incubator set to 125 rpm.
3. Next day, add the appropriate volume of titered P1 virus to achieve an optimal 
MOI and place back at 27 °C overnight.
4. Next day, transfer culture to another temperature, if necessary.
5. End the expression after optimized time and temperature based on results from 
Subheading 3.9.1.
6. Harvest 50 mL culture by transferring contents to a sterile 50 mL conical tube 
and centrifuging at 4000 rpm for 10 min.
7. Decant media supernatant and discard.
8. Add 10–20 mL Resuspension buffer to cells, vortex to homogenize, place on ice, 
then sonicate with a small tip or handheld sonicator until complete lysis is 
achieved.
9. Centrifuge sample in ultracentrifuge at 100,000 × g (34,000 rpm) for 60 min (see 
Note 35).
10. Remove supernatant by decanting, then add 10–20 mL fresh Purification buffer 
and scrape off pelleted membranes (see Note 36).
11. Homogenize by dounce homogenizer.
34.This is a good point to test alternate detergents, and how they affect amount of protein solubilized and thermostability compared to 
βDDM. In our experience the best way to test the effects of detergents on stability is to solubilize the protein from a fresh batch of 
cells in a panel of detergents, and not to exchange post-solubilized βDDM samples into other detergents. The CMC of βDDM is very 
low and the exchange rate is very slow, so attempting an exchange could confound the effect of the new detergent.
35.We use a Beckman-Coulter Type 50.2 Ti rotor for these purposes.
36.Purification buffer is Resuspension buffer plus additives discovered to increase stability as determined by the F-SEC-coupled 
thermostability assay outlined in Subheading 3.9.2.
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12. Split sample into 5–10 aliquots and perform small-scale IMAC and SEC 
purifications using different buffer variables.
13. Track purification via F-SEC and in-gel SDS-PAGE to determine protein 
homogeneity, monodispersity, and purity per Subheadings 3.5 and 3.6.1.
14. Repeat steps 1–13 iteratively, altering factors such as solubilizing detergent type 
and concentration, pH and buffer type, ionic strength and salt type, et al.
15. Combine small-scale purifications with F-SEC-coupled thermostability assay 
until optimal protein homogeneity, monodispersity, and stability is achieved.
16. Use sample(s) for structure–function analyses (see Note 37).
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Fig. 1. 
In vivo POI expression levels from transient transfection of HEK-293T cells in a 24-well 
culture plate. Overlay of bright field and eGFP fluorescence images using fluorescence 
microscopy of 18 POI membrane protein orthologs, with exposure times normalized to that 
of the brightest sample. The negative control represents cells transfected with a non-eGFP 
vector containing a CMV promoter, while the vector control was transfected with pEGFP-
N3mod, which contains eGFP but no POI. Transfection efficiencies can be quantified by 
calculating the number of fluorescent cells per total cells, while approximates of total cell 
expression can be ascertained by quantifying the number and fluorescence intensity per cell
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Fig. 2. 
HTP expression and homogeneity screening of membrane proteins transiently transfected in 
human cells using F-SEC. GFP fluorescence (λex = 488 nm, λem = 509 nm) was monitored 
while performing size-exclusion chromatography on 18 βDDM-solubilized POI membrane 
protein orthologs. The SEC peak heights provide an implication to the level of expression, 
while the trace symmetry indicates the quality of each protein screened. Analysis of the 
above results shows many sharp, monodisperse peaks, with highly variable levels of 
expression. Red, yellow, and green bars indicate three estimated classes of expressers; red 
being poor, yellow as moderate, and green as high. Note the aggregated (void) and 
proteolyzed (eGFP) peak intensities compared to POI-eGFP fusion peaks when analyzing 
results and deciding on targets
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Fig. 3. 
HTP expression and homogeneity screening of membrane proteins transiently transfected in 
human cells using in-gel fluorescence. GFP fluorescence (λex = 488 nm, λem = 509 nm) 
was monitored in-gel after SDS and Native-PAGE electrophoresis on 18 βDDM solubilized 
POI membrane protein orthologs. The fluorescence intensities from SDS-PAGE provide an 
implication to the level of expression, while the Native-PAGE intensities hint at potential 
oligomerization or aggregation. (Top panel) The same 20 samples used for microscopy (Fig. 
1) and F-SEC (Fig. 2) were subjected to SDS-PAGE without boiling and analyzed for in-gel 
fluorescence. In-gel fluorescence intensities correlate to peak intensities, but not 
monodispersity from F-SEC. Because this technique is not predictive of sample 
homogeneity, it should be used in conjunction with F-SEC. (Bottom panel) Native-PAGE in-
gel fluorescence using Blue Native-PAGE (Coomassie G-250) on ten top expressers from F-
SEC shows quenching of GFP fluorescence by the blue dye (left), while Clear Native-PAGE 
(βDDM with sodium deoxycholate) on five top expressers shows no interference by 
detergent on fluorescence (right). The + in this gel indicates the addition of 300 μM 2-
mercaptoethanol to the samples
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Fig. 4. 
HTP POI membrane protein expression optimization in Sf9 suspension cultures. GFP 
fluorescence (λex = 488 nm, λem = 509 nm) was monitored in-gel after SDS electrophoresis 
on a top expressing βDDM-solubilized membrane protein target. The fluorescence 
intensities from SDS-PAGE provide an implication to the level of expression when altering 
common Sf9 cell expression parameters such as time, temperature, and MOI. Here, three 
cultures with various MOIs were left at 27 °C for the entirety of the experiment (left), while 
three duplicate cultures were moved to 23 °C, 24 h post-infection (right). 5 mL of cell 
suspension was removed every 24 h, up to 5 days for each of six culture; then cells were 
lysed, proteins solubilized with βDDM, ultracentrifuged, and subjected to SDS-PAGE. The 
top line label of the gel indicates time in hours, the middle line MOI used, and the bottom 
line incubation temperature. In this example, optimal expression is obtained at 72 h post-
infection using an MOI of 2.0 at a temperature of 23 °C (24 h at 27 °C and 48 h at 23 °C)
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Fig. 5. 
HTP POI membrane protein stability determination and optimization using F-SEC and SDS-
PAGE. GFP fluorescence (λex = 488 nm, λem = 509 nm) was monitored while performing 
SEC and in-gel after SDS-PAGE on two top expressing βDDM-solubilized membrane 
protein targets. (a) Target A after solubilization was placed in thin-wall PCR tubes and 
heated to various temperatures for 10 min then injected on a SEC column. (b) Target B was 
treated identically to A. (c) After determining target A’s Tm, two small molecules were 
added to 4 °C SEC buffer and the sample was heated to 65 °C to assess their prevention on 
thermal denaturation. Here, ~50% more protein is recovered compared to 65 °C control 
when cholesterol hemisuccinate is included before heat challenge. (d) SDS-PAGE in-gel 
fluorescence of samples used for F-SEC in a and b shows a correlative loss of intensity 
using both methods; target B’s concentration fades at lower temperatures (60 °C) compared 
to target A, indicating a lower Tm (top). Indeed, plotting F-SEC fluorescence intensity in a 
and b versus temperature, target B’s melting transition occurs at 53 °C while A’s happens at 
63 °C (bottom). These are the temperatures to test additive effects on Tm
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